Cell-mediated immunity in patients with malignant melanoma.

Depression of lymphocyte responses after surgical trauma. Br J Exp Pathol (1973) 1.29

A study of cellular inflammatory reaction in human malignant melanoma, using in vitro-labelling techniques with h3-thymidine. Arch Dermatol Forsch (1974) 0.83

Formalinized tumour cells in the leucocyte migration inhibition test. Clin Exp Immunol (1975) 0.83

Comparative histological studies of regional lymph nodes of 201 melanoma patients. (Microscopic features in relation to individual age, site, and metastatic spread). Arch Dermatol Res (1979) 0.78

Lymphocyte stimulation in the cellular inflammatory reaction of some human skin tumours. Arch Dermatol Res (1975) 0.78

[Cellular immunity in melanomalignome (author's transl)]. Arch Dermatol Res (1976) 0.76

Cellular immunity to breast carcinoma and malignant melanoma. Br J Cancer Suppl (1973) 0.75

[Mitogenic activity of melanoma extracts in leucocyte cultures (author's transl)]. Arch Dermatol Res (1975) 0.75

Human malignant melanoma antigenic properties of phenol water extracts. Arch Dermatol Res (1979) 0.75

Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg (1992) 9.97

Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg (1999) 3.56

Role of metals in oxygen radical reactions. J Free Radic Biol Med (1985) 3.22

Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease. Ophthalmology (1985) 2.89

The classification of malignant melanoma and its histologic reporting. Cancer (1973) 2.67

Species-specific uptake of DNA by gonococci is mediated by a 10-base-pair sequence. J Bacteriol (1991) 2.64

The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanoma. Br J Dermatol (2004) 2.07

Systemic complement activation in psoriasis vulgaris. Clin Exp Dermatol (1996) 1.94

Tanning with ultraviolet A sunbeds. BMJ (1990) 1.93

Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease. Br Med J (1972) 1.84

Perilesional blood flow and edema formation in acute intracerebral hemorrhage: a SPECT study. Stroke (1998) 1.68

Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases. Arch Dermatol (1998) 1.60

Characterization of the hgbA locus encoding a hemoglobin receptor from Haemophilus ducreyi. Infect Immun (1995) 1.56

Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Programme. Hum Pathol (1991) 1.54

Paragangliomas: assessment of prognosis by histologic, immunohistochemical, and ultrastructural techniques. Hum Pathol (1989) 1.52

A review of the histology, ultrastructure, immunohistology, and molecular biology of extra-adrenal paragangliomas. Arch Pathol Lab Med (1989) 1.51

Ferritin and superoxide-dependent lipid peroxidation. J Biol Chem (1985) 1.51

Juvenile plantar dermatosis: a new entity?. Clin Exp Dermatol (1976) 1.51

Malignant melanoma. A REVIEW OF ') YEARS' experience in Glasgow, Scotland. Cancer (1969) 1.40

Assessment of an anti-T-cell receptor variable region antibody panel in cutaneous T-cell lymphoma. Br J Dermatol (1994) 1.39

Diagnostic immunopathology. West J Med (1986) 1.38

The suitability of SunCheck patches and Tanscan cards for monitoring the sunburning effectiveness of sunlight. Br J Dermatol (1993) 1.38

Detection of S-100 protein as an aid to the identification of melanocytic tumors. Int J Cancer (1982) 1.37

Health and the ozone layer. BMJ (1988) 1.37

UVA-induced melanocytic lesions. Br J Dermatol (1987) 1.35

The ultrastructure of human amnion epithelium. J Ultrastruct Res (1965) 1.32

Occult melanoma in lymph nodes detected by antiserum to S-100 protein. Int J Cancer (1984) 1.29

Golf science research at the beginning of the twenty-first century. J Sports Sci (2003) 1.29

Undiagnosed phaeochromocytoma mimicking severe preeclampsia in a pregnant woman at term. Int J Obstet Anesth (2006) 1.28

Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment. Neuroscience (2004) 1.27

Kinetic analysis of proton transport by the vanadate-sensitive ATPase from maize root microsomes. Plant Physiol (1989) 1.25

Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma. J Natl Cancer Inst (1993) 1.23

Melanoma from unknown primary site and amelanotic melanoma. Semin Oncol (1982) 1.20

Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation. Ann Neurol (1997) 1.19

Hemodynamic and single nephron function during the maintenance phase of ischemic acute renal failure in the dog. Kidney Int (1981) 1.16

Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes. Ann Surg (1982) 1.15

Inferring the origin of populations introduced from a genetically structured native range by approximate Bayesian computation: case study of the invasive ladybird Harmonia axyridis. Mol Ecol (2011) 1.15

Fine structure of the lung lesion in a case of paraquat poisoning. J Pathol (1970) 1.15

Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions. J Clin Pathol (1984) 1.14

Occult metastases in the axillary lymph nodes of patients with breast cancer node negative by clinical and histologic examination and conventional histology. Dis Markers (1992) 1.14

Studies of the melanocytes of the epidermis adjacent to tumors. J Invest Dermatol (1971) 1.13

Nodal nevi and cutaneous melanomas. Am J Surg Pathol (1996) 1.13

Zoned immune suppression of lymph nodes draining malignant melanoma: histologic and immunohistologic studies. J Natl Cancer Inst (1987) 1.10

Site-specific melanocytic naevus counts as predictors of whole body naevi. Br J Dermatol (1988) 1.09

Histology and prognosis in malignant melanoma. J Pathol (1969) 1.09

Tumor vascularity is not a prognostic factor for malignant melanoma of the skin. Am J Pathol (1995) 1.08

Cell-mediated immunity in malignant melanoma. Lancet (1972) 1.08

Establishment of an ascitic human melanoma cell line that metastasizes to lung and liver in nude mice. J Cancer Res Clin Oncol (1984) 1.07

Transient ischaemic attacks on patient with endothoracic goitre and congenital anomaly of the carotid arteries. Lancet (1982) 1.06

Assessment of prognosis in patients with malignant melanoma. Lancet (1972) 1.05

The classification of malignant melanoma, its histological reporting and registration: a revision of the 1972 Sydney classification. Pathology (1986) 1.05

The incidence of melanocytes in normal human skin. J Invest Dermatol (1970) 1.05

Herniated cervical discs. Analysis of a series of 230 cases. Acta Neurochir (Wien) (1986) 1.05

Suppressor cell activity in melanoma-draining lymph nodes. Cancer Res (1987) 1.04

Human hepatic triglyceride lipase expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice. J Biol Chem (1994) 1.04

Tyrosine crystals in salivary gland tumours. J Clin Pathol (1982) 1.04

Assessment of a contact-plate sampling technique and subsequent quantitative bacterial studies in atopic dermatitis. Br J Dermatol (1990) 1.04

Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi. Br J Dermatol (1994) 1.04

Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study. J Natl Cancer Inst (2010) 1.04

Results of administering B.C.G. to patients with melanoma. Lancet (1974) 1.04

Cellular fine structure in the invasive nodules of different histogenetic types of malignant melanoma. Br J Dermatol (1978) 1.03

Clinical accuracy of the diagnosis of cutaneous malignant melanoma. Br J Dermatol (1998) 1.03

The contribution of the C-terminal undecapeptide sequence of urogastrone-epidermal growth factor to its biological action. Regul Pept (1988) 1.02

Role of the Haemophilus ducreyi Ton system in internalization of heme from hemoglobin. Infect Immun (1998) 1.00

Reductive release of iron from ferritin by cation free radicals of paraquat and other bipyridyls. J Biol Chem (1986) 1.00

Superoxide generation by NADPH-cytochrome P-450 reductase: the effect of iron chelators and the role of superoxide in microsomal lipid peroxidation. Arch Biochem Biophys (1984) 0.98

Surface immunoglobulins of leukaemic cells. Clin Exp Immunol (1973) 0.98

A transsternal biclavicular approach to the upper anterior thoracic spine. Surg Neurol (1986) 0.98

Loss of beta2 microglobulin from the cell surface of cutaneous malignant and premalignant lesions. Br J Dermatol (1981) 0.98

Sensitization to tumour-associated antigens in human breast carcinoma. Int J Cancer (1974) 0.97

Cloning and sequencing of a Haemophilus ducreyi fur homolog. Gene (1996) 0.97

Neisserial TonB-dependent outer-membrane proteins: detection, regulation and distribution of three putative candidates identified from the genome sequences. Microbiology (2001) 0.97

Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing. J Am Coll Cardiol (1993) 0.96

Detection of cytoplasmic S-100 protein in primary and metastatic intraocular melanomas. Invest Ophthalmol Vis Sci (1983) 0.96

DNA immunization of mice with a plasmid encoding Neisseria gonorrhea PorB protein by intramuscular injection and epidermal particle bombardment. Vaccine (2004) 0.96

Seven-point checklist for melanoma. Clin Exp Dermatol (1991) 0.96

Design, synthesis, and in vitro evaluation of cyclic nitrones as free radical traps for the treatment of stroke. J Med Chem (1996) 0.96

Recurrence potential of thin primary melanomas. Cancer (1986) 0.95

Cloning, overexpression, purification, and immunobiology of an 85-kilodalton outer membrane protein from Haemophilus ducreyi. Infect Immun (2001) 0.95

Localized hirsutism after radical inguinal lymphadenectomy. N Engl J Med (1981) 0.95

Neisseria gonorrhoeae heme biosynthetic mutants utilize heme and hemoglobin as a heme source but fail to grow within epithelial cells. Infect Immun (1998) 0.95

Monoclonal antibodies in the diagnosis and treatment of carcinoma of the breast. Surg Gynecol Obstet (1989) 0.94

High-capacity, helper-dependent, "gutless" adenoviral vectors for gene transfer into brain. Methods Enzymol (2002) 0.93

Adjuvant interferon alpha 2b in high risk melanoma - the Scottish study. Br J Cancer (2001) 0.93

Induction of interleukin 1 beta expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadecadienoic acid. J Biol Chem (1992) 0.93

The spectrum of mutations in erythrokeratodermias--novel and de novo mutations in GJB3. Hum Genet (2000) 0.93

Variations in functional immunocompetence of individual tumor-draining lymph nodes in humans. Cancer Res (1987) 0.93

Asymmetry of intracranial hemodynamics as an indicator of mass effect in acute intracerebral hemorrhage. A transcranial Doppler study. Stroke (1996) 0.92

Pseudomembranous colitis after treatment with metronidazole. Br Med J (Clin Res Ed) (1981) 0.92

An immunohistochemical study of androgen, oestrogen and progesterone receptors in the vulva and vagina. Br J Obstet Gynaecol (1998) 0.92

Reactivity to neuroblastoma extracts in childhood cerebellar encephalopathy ("dancing eyes" syndrome) Lancet (1976) 0.91

Sensitisation of neuroblastoma patients and related and unrelated contacts to neuroblastoma extracts. Lancet (1976) 0.91

The morphology, immunophenotype and distribution of paracortical dendritic leucocytes in lymph nodes regional to cutaneous melanoma. Melanoma Res (2001) 0.90

Immunology and malignant disease. Haematologia (Budap) (1971) 0.90